
Re-bleeding risks can be managed during surgery but may later evolve into more severe complications, particularly in high-risk patients. Using a fibrin sealant can help mitigate these risks, as it forms a clot regardless of the patient's coagulation status. Discover our range of adjunctive hemostats ►
More J&J MedTech Biosurgery videos here ►
Subscribe to J&J MedTech and stay tuned for the latest innovations in surgical procedures and medical devices:
Follow us on Twitter at
Follow us on LinkedIn at
To view additional on-demand online learning resources, visit
Follow J&J Institute on LinkedIn at
Follow J&J Institute on Twitter at
#JnJMedTech #Hemostasis #Biosurgery
This video addresses surgical re-bleeding risks and how to best manage them.
US_ETH_BIOS_301310